Despite detailed analysis of the HIV-1-specific cytotoxic T lymphocyte response by various groups, its relation to viral load and viral sequence variation remains controversial. We analyzed HLA-A*0201 restricted cytotoxic T lymphocyte responses in 17 HIV-1-infected individuals with viral loads ranging from < 400 to 221,000 HIV RNA molecules per milliliter of plasma. In 13 out of 17 infected subjects, CTL responses against the SLYNTVATL epitope (p17 Gag; aa 77-85) were detectable, whereas two other HLA-A*0201 restricted epitopes (ILKEPVHGV, IV9; and VIYQYMDDL, VL9) were only recognized by six and five individuals out of 17 individuals tested, respectively. Naturally occurring variants of the SL9 epitope were tested for binding to HLA-A*0201 and for recognition by specific T cell clones generated from five individuals. Although these variants were widely recognized, they differed by up to 10,000-fold in terms of variant peptide concentrations required for lysis of target cells. A comparison of viral sequences derived from 10 HLA-A*0201-positive individuals to sequences obtained from 11 HLA-A*0201-negative individuals demonstrated only weak evidence for immune selective pressure and thus question the in vivo efficacy of immunodominant CTL responses present during chronic HIV-1 infection.
C Brander, K E Hartman, A K Trocha, N G Jones, R P Johnson, B Korber, P Wentworth, S P Buchbinder, S Wolinsky, B D Walker, S A Kalams
Title and authors | Publication | Year |
---|---|---|
Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses
CW Pohlmeyer, SB Laskey, SE Beck, DC Xu, AA Capoferri, CC Garliss, ME May, A Livingston, W Lichmira, RD Moore, MS Leffell, NJ Butler, JE Thorne, JA Flynn, RF Siliciano, JN Blankson, D Unutmaz |
PloS one | 2018 |
Genetic Strategies for HIV Treatment and Prevention
A Falkenhagen, S Joshi |
Molecular Therapy — Nucleic Acids | 2018 |
Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques
X Hu, Z Lu, A Valentin, M Rosati, KE Broderick, NY Sardesai, PA Marx, JI Mullins, GN Pavlakis, BK Felber |
Human Vaccines & Immunotherapeutics | 2018 |